Efficacy of roxadustat in treatment of peritoneal dialysis patients with renal anaemia

Figure 1 Haemoglobin trend and effects of roxadustat on haemoglobin changes. A: Haemoglobin (Hb) trend chart in cases 1-10; B: e Hb trend chart in cases 11-20; C: Hb trend chart in cases 21-29; D: Effects of roxadustat on Hb changes. Paired t test was performed to analyse the differences between before and after the intervention. ^bP < 0.001. Hb: Haemoglobin; EPO: Erythropoietin.

Figure 2 Effects of roxadustat on changes in ferritin, transferrin, and serum iron. A: Effects of roxadustat on ferritin changes; B: Effects of roxadustat on iron; C: Effects of roxadustat on transferrin; D: Effects of roxadustat on transferrin saturation. Paired t test was performed to analyse the differences between before and after the intervention. ^aP < 0.05; ^bP < 0.001. TSAT: Transferrin saturation; EPO: Erythropoietin.

Figure 3 Effects of roxadustat on blood lipids. A: Effects of roxadustat on total cholesterol; B: Effects of roxadustat on low-density lipoprotein cholesterol; C: Effects of roxadustat on high-density lipoprotein cholesterol; D: Effects of roxadustat on triglyceride. Paired t test was performed to analyse the differences between before and after the intervention. TC: Total cholesterol; LDL-C: Low-density lipoprotein cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; EPO: Erythropoietin.